Biocat has experience in accelerating healthcare projects and developing talent since 2008. In 2013, in order to increase the impact of these strategic activities. Biocat launched Moebio, a new initiative that brings together diferent training programs to accelerate entrepreneurship and innovation in healthcare, that counts with the support of EIT Health. Moebio is ranked as one of the top accelerators in Europe according to rankings by Digitalhealth.careers, Mobile World Capital, Tech EU and HealthStartup.
Moebio brings together several different training programs of various lengths, all of which aim to promote entrepreneurship and innovation at the intersection of technology, biosciences, health and business management. This portfolio is designed to offer advanced programs able to address healthcare current challenges from a global perspective. In order to this end, Moebio counts on the valuable expertise of an Advisory Board composed by the following international experts: Christer Windeløv-Lidzélius (from Danish entrepreneurial school KaosPilot), John Collins (CIMIT, Boston), Dan E. Azagury (Ciel Medical, Geneva), Yossi Bahagon (Clalit Health Services, Jerusalem), Chia Hwu (Qubop, Silicon Valley), David Maltz (Novartis, Silicon Valley), Lekshmy Parameswaran (Fuelfor, Barcelona-Singapore), Menno Van Dijk (The Amsterdam School of Creative Leadership), Neo Kok-Beng (Stanford Biodesign, Singapore), Lluís Torner (ICFO, Barcelona), and Xavier Verdaguer (Imagine, Barcelona-Silicon Valley), among others.
CRAASH Barcelona is a 3-month program that helps research teams and entrepreneurs bring to market their innovations in the areas of medical devices, diagnostics, and digital health that contribute to improved health and patient care. Selected projects will be guided by expert mentors from around Europe and CIMIT (Boston), the most experienced accelerator in the world. Over 20 years, CIMIT has successfully accelerated more than 600 healthtech projects, doubled the commercialization rate and reduced the time to market by more than half.
Biocat has opened the call to take part in the 4th annual CRAASH Barcelona, which will start in September 2021. The program this year, with a hybrid format that combines virtual and in-person sessions, is exclusively for projects related to the field of medical devices, diagnostics or digital health that have come out of research centers and institutes, universities or are promoted by an entrepreneur based on (or with a link) to the BioRegion.
The program is broken down into three phases:
Design Health Barcelona (d·HEALTH Barcelona) is a 9-month postgraduate program to develop entrepreneurs and future leaders in healthcare innovation. The course, based on the prestigious Stanford University's Biodesign Fellowship, has a needs-driven innovation focus and it guides multidisciplinary groups of students through a full cycle of innovation, from needs identification to designing and prototyping a viable solution, as well as searching for funding.
“Probably the best healthcare innovation accelerator in Europe” according to Health Startup Europe, the program collaborates with Hospital Clínic, Hospital Sant Joan de Déu, Vall d’Hebron Barcelona Hospital Campus, Institut Guttmann and Hospital Can Ruti, and the seventh edition started in January 2020.
d·HEALTH Barcelona is part of the Innovation Fellowships program of EIT Health, the main European consortium in health, which gives fellows opportunities for international mobility with other programs and to be part of the extensive European EIT Alumni network after finishing the program.
Previous editions have led to several business projects and 95% of the fellows find a job in the healthcare sector.
In 2014, the initiative also launched its MOEBIO Short Programs, training courses taken from the d·HEALTH Barcelona program that are open to all members of the BioRegion and deal with key issues in healthcare, innovation, management and entrepreneurialism.